With a roadmap now in place to lead the UK out of the coronavirus pandemic, Business Leader has profiled 32 of the UK’s leading HealthTech firms that will be driving the agenda for the future of business, wellbeing, and health.
According to The Association of British HealthTech Industries (ABHI) there are currently 4,060 companies that work in the sector, employing over 130,000 people and have a combined turnover of more than £25bn.
How have the top 32 been chosen?
Whether they are already established or a disruptive entity, these are the companies that are leading the sector into the future.
The men, women and companies on this list have been suggested by our readers, however, if you feel there are other individuals that are deserving, please email firstname.lastname@example.org.
This list is in no particular order.
Now entering its fifth year, Doctorlink’s algorithms are medico-legal compliant and indemnified with rigorous clinical governance and licensed independent peer review. Built by a team of healthcare and tech experts, its algorithms utilise AI and machine learning to gain a user access to the correct medical advice. Much like other innovators within the industry, its app allows video consultations and its platform has over 1300 practices across the UK – and has provided 62 million health assessments. It has so far raised almost £40m in funding.
Dr Ben Maruthappu
The London-based firm is revolutionising homecare and has raised more than £70m in funding in the six years it has existed, in order to provide pensioners with various care services. Cera’s app allows the right carers to be matched with the right patients – whether it is for offering medical support, or personal services such as shopping. The app tracks and monitors visits for loved ones and helps create personal care plans for patients.
Maidstone-based Vivosight’s flagship product, VivoSight Dx, is a state-of-the art Optical Coherence Tomography (OCT) system. OCT images and measurements give scientists and clinicians access to valuable information about the skin not readily available by other means, meaning it can provide highly cost-effective, unique OCT applications for everyday use in skin research facilities and dermatology practices. The non-invasive medical scanner is used by dermatologists to diagnose non-melanoma skin cancer.
Manchester-based Push Doctor has raised more than £44m in funding since it was founded in July 2013, to expand its digital on-demand GP consultation. After creating an account, a user can book an appointment at their convenience. A GMC-registered doctor can then diagnose entirely through video, live call, or text chat. Private prescriptions, sick notes and referrals can all be given through the platform.
Since its creation a decade ago, Huma has established itself as a leading healthtech provider. Huma uses remote patient monitoring to provide continuous, real-world data for research and healthcare organisations. Clinicians and researchers can care for patients at home and run clinical trials by tracking symptoms and vital signs. The platform can integrate with medical devices, offers telemedicine and uses digital biomarkers to give insight into people’s health.
Lumeon is a digital healthtech firm leveraging Care Journey Orchestration (CJO) to take a fresh approach to healthcare delivery. Over the past fifteen years, the company has helped some of the leading healthcare providers in the US and Europe to create better coordinated patient care journeys. Its platform enables providers to create and automate programmable care journeys. Its platform supports over 11 million patients across clients in the USA and UK.
Lantum is a workforce management platform that makes it easier for healthcare providers to mobilise their workforce, and for clinicians to work more flexibly. The scheduling platform allows users to cut admin time and reduce costs. Founded by Morris in 2012 after working as part of the NHS, she saw first-hand how inefficiencies in staffing were drastically affecting the quality of care available to patients. She knew that by using technology to break down the barriers between practice managers, who need to fill vacant sessions, and GPs, looking for a more flexible way of working, patients would see an increase in the quality of care they were receiving.
Charlotte Casebourne & Margaret Duffy
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, the company’s phenotypic screening platform enables the discovery and development of effective, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. Oncolytic viruses have the capability to selectively infect, replicate in, and kill cancer cells.
Born out of the Oxford University Institute of Biomedical Engineering, Oxevision platform enables staff to both plan patient care better and to intervene proactively to help patients. Unlike conventional remote patient monitoring companies, Oxevision includes a contact-free optical sensor which detects patient vital signs and behaviour and delivers a secure on demand video feed. Oxevision provides staff with a wider range of clinically validated early warning signs and risk factors than any other technology, plus the ability to check the patient visually before choosing their intervention.
Dr Maria Karvela & Professor Chris Toumazou
This Imperial College spin-out is a digital genetic testing service that provides users with tailored food and health recommendations based on their DNA. Users must first provide a sample of their DNA, which is collected through a cheek swab – and is then digitised through the firm’s ‘DNACatridge’. A user’s ‘digital DNA’ is available through their app. Users are then given a wearable ‘DNABand’, which enables them to scan thousands of products to assess whether they are an appropriate match for their biology. The wearable tech is also used to monitor physical inactivity – encouraging its users to be more physically active.
Dr Ali Parsa
Founded in 2014, start-up unicorn Babylon Health utilises artificial intelligence diagnostic software to provide a range of healthcare services through its ‘Ask Babylon’ tool. The firm’s innovative tech allows users to enter their symptoms and analyse millions of data samples from doctors and scientists to replicate a diagnosis. The tech also offers live video/audio chats – meaning that prescriptions can be issued electronically. Babylon Health has raised more than £500m in funding.
Zava online doctor is a discreet and convenient way to get medical treatment, wherever and whenever needed. Simply complete a digital medical questionnaire, place an order and their doctors will check a suitable treatment for a user, which will then be sent out safely and securely to your chosen address. The online doctor service continues through the treatment and an individual can contact one of Zava’s doctors free of charge. Zava has carried out over five million consultations to patients in the UK, Ireland, France and Germany.
Dr Faz Chowdhury
Founded in 2011, Nemaura Medical set out to develop a single platform technology using non-invasive microsystems to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital healthcare solutions that encourage and empower people to take charge of their own health and wellbeing.
Doctor Care Anywhere
Dr Bayju Thakar
This digital healthcare firm brings together primary care, diagnostics and secondary care services allowing clinicians to deliver end-to-end patient care across a range of non-emergency health issues. After booking an appointment through its digital platform, patients can schedule phone call or video consultations with highly trained GPs, and if appropriate, be issued with prescriptions, doctor notes and specialist referrals all recorded under a single, patient accessible, Electronic Health Record.
Dr Nick Taylor
Unmind is a workplace mental health platform, that empowers employees to live more fulfilling and balanced lives by changing the way organisations think about health and wellbeing through clinically-backed digital tools. From helping to reduce stress to aiding people’s sleep, the company has become a trusted partner to some of the UK’s largest employers, such as British Airways and Just Eat.
Dr Tim Guillams
Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. The company’s AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases. Combining this technology with patient insights and drug discovery expertise, its mission is to advance 100 rare disease treatments towards the clinic by 2025.
Dr James Field
LabGenius develops next-generation protein therapeutics using a machine learning-driven evolution engine (EVA). The company uses robotic automation, synthetic biology and advanced machine learning to explore protein fitness landscapes and improve multiple drug properties simultaneously. LabGenius is a privately-owned company, backed by top-tier venture capital funds, currently based in London. So far, the company has raised more than £12m to develop its technology.
Founded six years ago, Oviva makes accessing expert nutrition and lifestyle advice easily accessible through its innovative smartphone app. From diabetes, to undernutrition, to milk protein allergies, Oviva helps users to improve health choices. Their healthcare professionals offer a range of approaches, including phone calls and advice through the app – meaning individuals can receive care at home at a time that suits them. Oviva is a trusted NHS partner and has raised more than £25m in funding to develop its tech.
Dr David Tuch
Buckinghamshire-based Lightpoint Medical is a technology leader in precision-guided robotic cancer surgery. The company is developing miniaturised imaging and sensing tools for advanced intra-operative cancer detection. Their mission is to improve the lives of people with cancer by transforming the efficacy of robotic surgery. Lightpoint has two miniaturised robotic probes in development. The probes aim to accurately identify cancer, enabling the full removal of diseased tissue, or confirm its absence, helping to preserve healthy, functional tissue.
Free prescription management app Echo allows patients to easily manage repeat medical courses, including home deliveries. The app lets you know when to renew a prescription, where a local GP/pharmacy is and details you’d normally get visiting your local doctor. Described as the ‘Deliveroo for prescriptions’ this innovative firm is now a part of the Lloyds Pharmacy Group and the NHS Innovation Accelerator. More than 425,000 people currently use the service.
Gabriel Mecklenburg & Daniel Perez
Hinge Health is pioneering the world’s most patient-centred ‘Digital Clinic’ for back & joint pain. The company’s clinic is the top musculoskeletal (MSK) solution for employers and health plans. MSK conditions are one of the top medical spends for employers and Hinge Health is making it easier to bring expert-recommended care to millions of patients, by being the first company to combine wearable-sensor guided exercise therapy with one-on-one PTs, health coaching, and patient education.
Philip Mundy, Dr Lydia Yarlott, Dr Barney Gilbert
Pando is a clinical communications platform that offers a variety of features built for health and social care workers. Secure messaging, image sharing, patient lists, open forums, active directory and file sharing enable clinical professionals to deliver the best possible care. With over 65,000 users, Pando is one of the UK’s leading clinical messaging systems. The app is available on iOS and Android.
Another industry-leading innovator from the Oxford-Cambridge region, Owlstone Medical has developed a breathalyser for disease. With a focus on non-invasive diagnostics for cancer, inflammatory diseases and other conditions, the company’s mission is to save 100,000 lives and $1.5bn in healthcare costs by advancing early detection and precision medicine.
The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions.
London-headquartered LumiraDx’s platform is a diagnostic system which combines a small, portable instrument, test strip and allows for remote management and data sharing through digital connectivity. Since it was founded in 2014, it has raised more than £30m funding to expand its smart diagnostic platform to allow individuals to self-care under the guidance of care teams. The company has now expanded to the USA, and has offices in Massachusetts.
Dr Abdullah Albeyatti
Medicalchain uses blockchain technology to create a user-focused electronic health record whilst maintaining a single true version of the user’s data. Medicalchain enables the user to give healthcare professional access to their personal health data and then records interactions with this data in an auditable, transparent and secure way on Medicalchain’s distributed ledger. The platform can be used to build applications that complement and improve the user experience, meaning that they will be able to leverage their medical data to power a plethora of applications and services.
Christopher McCann & Stewart Whiting
The Edinburgh-based tech innovator has raised more than £20m in funding since its creation in 2014 and is a remote patient monitoring platform. Through this platform, Current Health is able to achieve its mission of ensuring every human has the ability to lead a healthier and longer life by predicting disease onset and delivering treatment earlier through its digital solutions.
Oxford Nanopore Technologies
Dr Gordon Sanghera
The Oxford-headquartered tech innovator has developed the world’s first and only nanopore DNA and RNA sequencing platform. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The company has a track record of delivering disruptive technologies to the market.
The femtech innovator is a health and lifestyle brand developing smarter technology for women. Its first product, Elvie Trainer, is an award-winning app-connected Kegel trainer that helps women strengthen the pelvic floor via fun, five-minute workouts. They recently launched their second innovation: Elvie Pump, the world’s first silent wearable breast pump, which is making it possible for new mothers to pump anytime, anywhere. They recently received $42m Series B funding and opened an office in New York.
Eliot Brooks, Hamish Grierson & Tom Livesey
Thriva is the UK’s most convenient, at-home finger-prick blood test. All tests are analysed by Thriva’s partner laboratories, and results are reviewed by a GP. Patients then receive their results through the Thriva dashboard, with commentary on the results, along with any areas that might require some improvement. The process is simple; order a test through Thriva; do the test and send it back; and then receive the results within 48 hours.
Joel Gibbard & Samantha Payne
Open Bionics is ‘turning disabilities into superpowers’ by building and developing the next generation of bionic limbs. The Hero Arm is the world’s first clinically approved 3D-printed bionic arm, with multi-grip functionality and empowering aesthetics.
Engineered in Bristol, it is a lightweight and affordable prosthetic, available now in the UK, USA, Europe, Australia and New Zealand, for below elbow amputee adults and children aged eight and above.
Georgina Kirby & Rayna Patel
The Vinehealth app allows people living with cancer to track their symptoms, manage their medications and understand their care – putting cancer patients back in control of their treatment. Vinehealth is free to download from the Apple App store and Google Play store. The company has worked with oncologists, specialist cancer nurses and patients to build an app allowing patients to easily report and monitor their symptoms
Kheiron Medical Technologies
Dr Peter Kecskemethy
KHM’s mission is to help breast cancer patients live longer, better lives through earlier detection. The company’s industry leading technology combines new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening.